Related Experiment Videos
Theophylline affects sleep-wake state development in premature infants
Insights
Theophylline given to premature infants for apnea may alter their sleep-wake state organization long after the medication is stopped. These developmental effects persisted even when the drug was no longer detectable.
Area of Science:
- Neonatal development
- Developmental neuroscience
- Pharmacology
Background:
- Apnea of prematurity is a common condition in preterm infants.
- Theophylline is a medication used to treat apnea of prematurity.
- Understanding the long-term effects of neonatal medication is crucial for infant health.
Purpose of the Study:
- To investigate the prolonged effects of theophylline on infant state behavior.
- To determine if theophylline's impact on state organization persists after drug clearance.
Main Methods:
- Compared sleep-wake states in three groups of infants: preterm infants previously treated with theophylline, preterm infants never treated with theophylline, and normal full-term infants.
- Observed sleep-wake states in the home for seven-hour periods at corrected ages of 2, 3, 4, and 5 weeks post-term.
- Analyzed data from periods when infants were alone to assess state organization.
Main Results:
- The theophylline-exposed group showed significantly different state organization compared to the other two groups.
- The theophylline group exhibited more non-alert waking, alert, and drowsy/transition states, and less active sleep.
- No significant differences were found between the non-theophylline preterm and full-term infant groups.
Conclusions:
- Theophylline administration appears to alter the normal development of state organization in premature infants.
- These observed behavioral effects persisted long after the theophylline had cleared from the infants' systems.
- Findings suggest potential long-term neurodevelopmental impacts of theophylline in preterm infants.
Abstract:
This study investigated the prolonged effects on state behavior of theophylline administered to infants for apnea of prematurity. There were three groups: Four premature infants who had received theophylline in the preterm period, five premature infants who had not received theophylline, and twenty-eight normal fullterm infants. The Theophylline infants had been off the drug for at least one month prior to the beginning of the study. Sleep-wake states were observed in the home for seven-hour periods when all infants were the same corrected ages: two, three, four and five weeks post-term. Data from the portion of the day that the infants were alone were analysed for this study. The state organization of the Theophylline group differed significantly from those of the other groups. They exhibited more non-alert waking activity, more alert, more drowse or transition, and less active sleep than did the Non-Theophylline and Fullterm infants. The state distributions of the latter two groups did not differ. On the basis of similarities between the results of this study and of a previous animal study, it was concluded that theophylline altered the normal development of state organization in premature infants. These effects persisted long after the drug had cleared the body.